½ÃÀ庸°í¼­
»óǰÄÚµå
1747600

ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, Áö¿ªº°

Molecular Cytogenetics Market, By Product Type, By Technology, By Application, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀåÀº 2025³â¿¡´Â 65¾ï 2,720¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 302¾ï 6,300¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â CAGR 24.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 65¾ï 2,720¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) : 24.50% ¿¹Ãø ±Ý¾×(2032³â) 302¾ï 6,300¸¸ ´Þ·¯

ºÐÀÚ¼¼Æ÷ À¯ÀüÇп¡´Â ºÐÀÚ»ý¹°Çаú ¼¼Æ÷À¯ÀüÇÐÀÇ Á¶ÇÕÀÌ Æ÷ÇԵ˴ϴÙ. ºÐÀÚ¼¼Æ÷ À¯ÀüÇп¡´Â ¿°»öü »ý¹°ÇÐÀÇ ¸ðµç Ãø¸éÀÌ Æ÷ÇԵǾî Áúȯ Áø´ÜÀ̳ª ¿°»öü ÀÌ»ó¿¡ À־ Æø³ÐÀº ¿ëµµ°¡ °¡´ÉÇÕ´Ï´Ù. ºÐÀÚ¼¼Æ÷ À¯ÀüÇп¡¼­´Â Á¤»ó ¼¼Æ÷¿Í ¾Ï ¼¼Æ÷¸¦ ±¸º°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÐÀÚ¼¼Æ÷ À¯ÀüÇп¡¼­´Â DNA p·Îºê¸¦ ´Ù¸¥ »ö»óÀÇ Çü±¤ ű׷Πǥ½ÃÇÏ¿© °Ô³ð Àüü ¶Ç´Â °Ô³ðÀÇ °¡Àå Æ¯ÀÌÀûÀÎ ¿µ¿ªÀ» °¡½ÃÈ­ÇÏ´Â Çü±¤ in situ ÇÏÀ̺긮µåÈ­(FISH) µîÀÇ ±â¼úÀÌ ½Ç½ÃµË´Ï´Ù. ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐÀº ¿°»öü ¹× ±× ÇÙÀÇ ±¸Á¶Àû ¹× ±â´ÉÀû Á¶Á÷, °Ô³ðÀÇ º¯ÀÌ, ¹ßÇö ¹× ÁøÈ­ ¹× ÀÇ¾à ¹× ¾Ï °ü·Ã À¯ÀüÇп¡¼­ÀÇ ¿°»öü ÀÌ»ó ¿¬±¸¿¡ µµ¿òÀ» ÁÝ´Ï´Ù. ³ôÀº ¾Ï À¯º´·ü°ú ¾Ï ½ÃÀå °³Ã´°ú °ü·ÃµÈ À¯ÀüÀû °¨¼ö¼º °ËÃâ¿¡¼­ÀÇ ºÐÀÚ»ý¹°ÇÐ ¿ëµµ Áõ°¡´Â ¼¼°è ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

÷´Ü PSS Çϵå¿þ¾î, ¼ÒÇÁÆ®¿þ¾î, Ä÷³, Ç¥Áع°ÁúÀ» Á¦Ç° Æ÷Æ®Æú¸®¿À¿¡ Ãß°¡ÇÔÀ¸·Î½á LC ÀåÄ¡, GPC/SEC ºÐ¼® µî ´Ù¾çÇÑ Á¦Ç° ¶óÀξ÷À» °­È­Çϰí È®½ÇÇÏ°Ô Á¦°øÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇØ, ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷Àº Àμö µîÀÇ ¼ºÀå Àü·«ÀÇ Ã¤¿ë¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, À̰ÍÀÌ ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 8¿ù ÀåÄ¡, ¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º µîÀ» Á¦°øÇÏ´Â Agilent Technologies Inc.´Â Æú¸®¸Ó Ư¼º Æò°¡ ºÐ¾ß ¼Ö·ç¼Ç °ø±Þ¾÷üÀÎ Polymer Standards Service GmbH(PSS)¸¦ ÀμöÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. PSS»ç´Â ºÐÀÚ±¸Á¶ÀÇ Á¤ÀÇ¿Í ÀÛ¼º¿¡ »ç¿ëµÇ´Â Çϵå¿þ¾î¿Í ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀ» Àü¹®À¸·Î Çϰí ÀÖ½À´Ï´Ù. µ¿»ç´Â, °íºÐÀÚÀÇ ºÐÀÚ·®°ú »çÀÌÁî ºÐÆ÷¸¦ ÃøÁ¤ÇÏ´Â ¾ÖÇø®ÄÉÀ̼ǿ¡¼­ »ç¿ëµÇ´Â °Ö ħÅõ Å©·Î¸¶Åä±×·¡ÇÇ(GPC)¿Í »çÀÌÁî ¹èÁ¦ Å©·Î¸¶Åä±×·¡ÇÇ(SEC)¸¦ À§ÇÑ ¿ÏÀüÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­´Â ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÑ ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù.
  • ¶Ç, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÇô, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ¼­ ÇØ¼³Çß½À´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±Ù°ÅÇØ, ¼¼°è ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.
  • º» º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ³ª ±â¾÷ÀÇ °æ¿µÁøÀº Àå·¡ÀÇ Á¦Ç° ¹ß¸Å, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ ¹× ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • ÀϰüµÈ ±âȸ Áöµµ(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÃÖ±Ù Á¦Ç° Ãâ½Ã
  • ¿ªÇÐ
  • ÇÕº´, Àμö ¹× Çù¾÷
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2032³â)

  • ±â±â
  • ¼Ò¸ðǰ
  • ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º

Á¦5Àå ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå : ±â¼úº°(2020-2032³â)

  • FISH
  • aCGH

Á¦6Àå ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå : ¿ëµµº°(2020-2032³â)

  • À¯Àü¼º Áúȯ
  • ¾Ï
  • ¸ÂÃãÇü ÀÇ·á
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå : Áö¿ªº°(2020-2032³â)

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • ASEAN
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
      • GCC
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó ¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Applied Spectral Imaging, Inc.
  • BI Biological Industries
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific Inc.
  • CytoTest Inc.
  • Cytognomix, Inc.
  • Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Bionano Genomics, Inc.
  • Precipio, Inc.
  • Leica Biosystems

Á¦9Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
AJY 25.06.23

Molecular Cytogenetics Market is estimated to be valued at USD 6,527.2 Mn in 2025 and is expected to reach USD 30,263 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 24.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6,527.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 24.50% 2032 Value Projection: USD 30,263 Mn

Molecular cytogenetics encompasses the combination of molecular biology and cytogenetics. Molecular cytogenetics includes all the aspects of chromosome biology with a wide range of applications in disease diagnosis and chromosomal abnormalities. It enables to differentiate normal and cancer causing cells. In molecular cytogenetics, techniques such as fluorescence in situ hybridization (FISH) are conducted wherein DNA probes are labeled with different colored fluorescent tags to visualize the whole genome or the most specific regions of the genome. Molecular cytogenetics helps to study the structural and functional organization of chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities in medicinal and cancer-related genetics. The high prevalence of cancer and increasing application of molecular biology in the detection of inherited susceptibilities associated with cancer development is expected to boost the global molecular cytogenetics market growth.

Market Dynamics

To add advanced PSS hardware, software, columns, and reference materials to the product portfolio which will enhance the offerings and ensure delivery of the broad spectrum of LC equipment, GPC/SEC analytics, the key market players are focusing on adoption of growth strategies such as acquisition which is attributed to the growth of global molecular cytogenetics market. For instance, in August 2022, Agilent Technologies Inc., provider of instruments, software, services, etc., announced it has acquired Polymer Standards Service GmbH (PSS) a provider of solutions in the field of polymer characterization. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules.

Key features of the study

  • This report provides an in-depth analysis of the global molecular cytogenetics market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global molecular cytogenetics market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global molecular cytogenetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular cytogenetics market

Market Segmentation

  • Global Molecular Cytogenetics Market, By Product Type
    • Instruments
    • Consumables
    • Software and Services
  • Global Molecular Cytogenetics Market, By Technology
    • FISH
    • aCGH
  • Global Molecular Cytogenetics Market, By Application
    • Genetic Disorders
    • Cancer
    • Personalized Medicine
    • Others
  • Global Molecular Cytogenetics Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Abbott Laboratories
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Applied Spectral Imaging, Inc.
    • BI Biological Industries
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific Inc.
    • CytoTest Inc.
    • Cytognomix, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Illumina Inc.
    • Bionano Genomics, Inc.
    • Precipio, Inc.
    • Leica Biosystems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Molecular Cytogenetics Market, By Product Type, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

5. Global Molecular Cytogenetics Market, By Technology, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • FISH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • aCGH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

6. Global Molecular Cytogenetics Market, By Application, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Genetic Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Molecular Cytogenetics Market, By Region, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Affymetrix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Applied Spectral Imaging, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BI Biological Industries
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CytoTest Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cytognomix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bionano Genomics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Precipio, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Leica Biosystems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦